Iveremectin don maganin Covid yana cikin shakka, amma buƙatu yana soaring

Kodayake akwai shakku na ainihi game da magunguna na dabbobi don dabbobi, wasu masana'antun ƙasashen waje ba su kulawa.
Kafin pandemic, TAJ Pharmaceuticals Ltd. Ana jigilar kayayyaki da yawa na ivermectin don amfani da dabbobi. Amma a cikin shekarar da ta gabata, ya zama sanannen mashahuri don masana'anta na masanin halittar India na India: tun watan Yuli 20, 2020, taj Pharma ta sayar da dala miliyan 5 a Indiya da kasashen waje. Don karamin kasuwancin iyali tare da samun kudin shiga na shekara-shekara na kusan dala miliyan 66, wannan arziki ne.
Tarawa na wannan magani, wanda aka ƙirƙira shi don kula da cututtukan da ke haifar da cutar ta dabbobi, sun tafi da shi a matsayin masu ba da shawara game da maganin anti-anti. Suna da'awar cewa idan kawai mutane ne kamar Dr. Anthony Fatauci, Daraktan Cibiyar Allergy da kamuwa da cuta, ta gan ta da pandemic. Shantanu ya ce "Muna aiki 24/7," in ji Shantanu Kumar Singh, dare 30 mai mulkin TAj Fir'auna. "Bukatar tayi girma."
Kamfanin yana da wuraren samar da kayan aiki takwas a Indiya kuma yana daya daga cikin masana'antun magunguna da yawa da yawa daga cikinsu wajen yin amfanewa daga cutar ivermectic na ivermeccin. Hukumar Lafiya ta Duniya da Gudanar da Abinci da Magunguna da ba a motsa su ba. Binciken Clinical ba tukuna nuna wata hujja game da tasiri ga miyagun ƙwayoyi game da cututtukan ƙwayar cutar coronavirus. Masu kera ba a hana su ba, sun ƙarfafa cigaban siyarwa da haɓaka samarwa.
IverMectin ya zama abin kula da hankalin da ya gabata bayan wasu karatun farko da aka nuna cewa Ivermetectin ana tsammanin zai zama mai yiwuwa ga COVID. Bayan shugaban kasar Brazil na Jair Bolonaro da sauran shugabannin duniya da masu aiwatarwa kamar Joe Roogtan sun fara shan ivermectin, likitocin a duk faɗin duniya suna fuskantar matsin lamba ga takarce.
Tunda Easter Patent ya ƙare a cikin 1996, ƙananan masana'antun magunguna kamar yadda aka sanya Aj Ajahal a samarwa, kuma sun ɗauki matsayi a sararin samaniya. Merck har yanzu yana sayar da Ivermectin a karkashin alamar Stomomactol, da kamfanin ya yi gargadin a watan Fabrairu cewa "babu shaida mai ma'ana ga COVID.
Koyaya, duk waɗannan shawarwarin ba su dakatar da miliyoyin Amurkawa daga samun magunguna daga likitocin da ke da kyau a shafukan yanar gizo na telefedicine ba. A cikin kwana bakwai da ke ƙarewa ranar 13 ga Agusta, yawan magunguna masu magani wanda aka gamsar da shi fiye da 24 sau goma daga matakan pre-pandemic, kai 88,000 a mako.
Ana amfani da Ivermetcin don magance cututtukan da ke tattare da mutane a cikin mutane da dabbobi. Floveberers, William Campbell da Satoshi omura, sun lashe kyautar Nobel a cikin Jami'ar Oxford, wasu karatuttukan sun nuna cewa ƙwayoyi na iya rage nauyin ƙwayoyin cuta na Cololid. Koyaya, bisa ga bita ta kwanan nan da Cochrane da Coachrane da ke da cuta, wanda ke kimanta aikin likita, da yawa na kimanta kan fa'idodin iveremectin ga marasa lafiya ne kuma basu da isasshen shaidu.
Jami'an kiwon lafiya sun gargadi cewa a wasu halaye, har ma da kashi ba daidai ba na ɗan adam sigar na iya haifar da tashin zuciya, ausa da tashin hankali. Kafofin yada labarai a Singapore sun ba da cikakken bayani a wannan watan a Facebook suna cewa yadda mahaifiyarta ta kauce wa alurar riga kafi. A karkashin tasirin abokai da ke halartar cocin, ta zama rashin lafiya mai rauni.
Duk da lamuran lafiyar da jerin guba, miyagun ƙwayoyi har yanzu suna shahara a cikin mutanen da suke ganin pandemical. Hakanan ya zama maganin zaɓi a cikin ƙasashe masu talauci waɗanda ke da damar samun damar haɗin gwiwa da ka'idojin lax. Akwai shi a kan counter, an nemi sosai bayan lokacin raira da Delta a Indiya.
Wasu magunguna suna da sha'awa. Taj Phar Farma ya bayyana cewa ba a yi jigilar Amurka ba kuma Ivermettacin ba wani yanki ne na kasuwancinta ba. Yana jan hankalin masu imani kuma ya ba da labari gama gari game da kafofin watsa labarun da masana'antar rigakafin da ke da himma a kan miyagun ƙwayoyi. An dakatar da asusun na shafin na ɗan lokaci bayan ta amfani da hashtags kamar #ivermectinworks don inganta magani.
A Indonesia, gwamnati ta fara shari'ar fitina a watan Yuni don gwada tasiri na ivermectin a kan COVID. A cikin wannan watan, jihar mallakar PT Indofarma ta fara aiwatar da fasalin gaba ɗaya-manufa. Tun daga wannan lokacin, ya rarraba fiye da kwalta sama da 334,000 na kwayoyin hana magunguna a duk fadin kasar. "Mu kasuwar Ivermectin a matsayin babban aikin magani na Antiparasitic," in ji Sakatare kamfanin, Sakatare da Sakatare da aka buga ya ce wasu rahotannin da aka buga ke da tasiri kan wannan cutar. "Yana da misalin likita na likita na likita don amfani dashi don wasu jiyya," in ji shi.
Ya zuwa yanzu, kasuwancin Ivermarma shine ƙanana, tare da jimlar kudaden da kamfanin ya samu na tiriliyan 1.7 ($ 120 miliyan) bara. A cikin watanni huɗu tun farkon samarwa, ƙwayoyi sun shigo da kudaden shiga na birai 360 biliyan. Koyaya, kamfanin yana ganin karin iyawa kuma yana shirin ƙaddamar da samfurin ivermet din da ake kira Ivercov 12 kafin ƙarshen shekara.
A bara gargaɗi ga masana'antu Perameutica Faristadididic Masana'antu SpalmaceDica ya sayar da Reais miliyan 470 a cikin 2019. Daraktan Reais ya ce, daga 15,7,000 reais a kan talla don inganta IVEMETISED 71.7 . 11 Ba'amures ga 'yan majalisar na Brazil, wanda ke binciken kula da gwamnatin da ke tattare da Pandemic. Kamfanin bai amsa wa bukatar yin sharhi ba.
A cikin ƙasashe inda akwai ƙarancin iveremectin don amfanin ɗan adam ko mutane ba sa iya samun wasu bambance-bambancen dabbobi waɗanda na iya haifar da haɗarin mummunan sakamako masu illa. Kamfanin Kasuwancin Kasuwanci na Kasa shine babban masana'antar maganin dabbobi a Afirka ta Kudu. Farashin samfuran Ivermectacin a cikin shagunan sayar da kayayyaki a kasar ya karu goma, kai kusan 1,000 Rand (US $ 66) a cikin 10,000 a cikin 10 ml. "Yana iya aiki ko kuma bazai aiki ba," in ji Bishon Peterem. "Mutane suna matsananciyar wahala." Kamfanin yana shigo da kayan aiki na maganin daga China, amma wani lokaci yana karewa daga hannun jari.
A watan Satumba, Majalisar likitan likitanta India ta cire miyagun ƙwayoyi daga jagorancin asibiti don gudanar da covid na manya. Duk da haka, kamfanonin Indiya da yawa na Indiya wajen samar da masana'antu mai ƙarancin masana'antu, gami da mafi yawan magunguna a Pune wanda ya tallafawa babban birnin Pun babban birnin Putun. Bajaj Lafiya Ltd. An bayyana a cikin wani takaddar da aka jima na 6 na Allah zai ƙaddamar da sabon alama Ivermet ɗin, ivejaj. Daraktan hadin gwiwar kamfanin, Anil Jain, wanda aka bayyana cewa alama za ta taimaka wajen inganta lafiyar masu haƙuri da masu cutar. Matsayin kiwon lafiya kuma ya samar musu da "da sauri da zaɓuɓɓukan magani na lokaci." GWAMNATI FADA FASAHA DA SARKIN SHAIMAL DA SANAR DA AIKI A CIKIN SAUKI DA BAJA CIGABA DA BIYULI BAYYANA AMFANI DA AMFANI DA MULKIN NA SAMA.
A cewar Sheppe, Shugaban Kasuwanci na PVT PVT., Wani kamfanin bincike na Indiya, miliyan 51) a cikin shekarar da ta ƙare a watan Agusta. . "Kamfanoni da yawa sun shiga kasuwa don amfani da wannan damar kuma sun ci gaba da amfani da shi," in ji ta. "Kamar yadda abin da ya faru na Clovid ya ragu sosai, wannan bazai gan shi ba a matsayin yanayin dogon lokaci."
Carlos Chacour, mataimaki mai mahimmanci farfesa a Cibiyar Lafiya ta Barcelona, ​​wacce ta yi nazarin ingancin cutar zazzabin cigaba, kamfanoni masu yawa sun yi shiru. "Wasu mutane suna cikin kamun kifi a cikin koguna na daji kuma suna amfani da wannan halin don samun riba," in ji shi.
Masana kwantar da kwastomomi na Bulgarie, wanda shima yana da masana'antu a Faransa, Italiya da Amurka, ba su sayar da gwamnatin gwamnati don yin rijistar COVID. , Amma amfani da bi da karfi. Cikakken kamuwa da cuta lalacewa ta hanyar zagaye. Streendlosidiasis bai faru a Bulgaria kwanan nan. Ban da haka, yarogin ya taimaka wajan kamfanin na Sofia wanda ya ba da izinin Ivermemectin zuwa magunguna, inda mutane za su iya siyan shi a matsayin takardar magani ba tare da izini tare da takardar sayan likita ba. Huvephrarma bai amsa wa bukatar ba.
Maria Helen Grace Perez-Florentino, Kasuwancin Kiwon Lafiya da kuma Batun Bincike na MotMectin, ya ce ko da wasu likitoci za su sake yin amfani da su a cikin hanyoyin da ba a ba da kai ba. Samfuran su. Lloyd rukunin Cos., Kamfanin ya fara rarraba yadda iveremectin a watan Mayu.
Dokta Zen ta dauki bakuncin taron kan layi biyu a kan miyagun ƙwayoyi na Filipin Likitoci da kuma gayyata masu magana daga kasashen waje don samar da bayanai kan sashi da sakamako masu illa. Perez-Florentino ya ce wannan yana da matukar amfani. "Muna magana da likitocin da suke shirye su yi amfani da Ivermectin," in ji ta. "Mun fahimci ilimin samfurin, sakamakon sa, kuma sashi ya dace. Muna sanar dasu."
Kamar merck, wasu masana'antun na miyagun ƙwayoyi sun yi gargadi game da cin zarafin Ivermectin. Waɗannan sun haɗa da masu riƙe Bimda a Ireland, wanda ke cikin Missouri da Boehringer Ingelheim a cikin Jamus. Amma sauran kamfanoni, kamar taj malcouticals, ba su yi haƙuri don kafa hanyar haɗi tsakanin iveremectin da covid, wanda ya buga labaran da ke inganta magani a shafin yanar gizon ta. Singh na Taj Fir'a ya ce kamfanin yana da alhakin. "Ba mu da'awar cewa ƙwayoyi suna da wani tasiri akan Covid," in ji Singh. "Da gaske ba mu san abin da zai yi aiki ba."
Wannan rashin tabbas bai daina hana kamfanin ba da magani kan kwayoyi a sake, kuma an dawo da asusun. Wani tweet a ranar 9 ga Oktoba ya inganta, magungunan Ivermetectin, an shirya shi da zinc acetate da doxycycline, kuma aka sanya sunayensu #covidids. - Karanta labarin na gaba tare da Daniel Carvalho, Fathiya Dahrul, Fathiya Dahrul, Ian in ji Scuzzin, Janice Kew da Cynthia na Cynthia: Homeopathy baya aiki. Don haka me yasa jeri na Jerin suka yarda da shi?